Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate 2021-02-01 14:00
Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants 2021-02-01 13:05
Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling innovator 2021-02-01 13:01
INEOS Styrolution Receives "2020 Public Welfare Practice Award" at the 10th China Charity Festival 2021-02-01 09:00
Antengene Announces Collaboration with WuXi Biologics and WuXi STA to Advance Antibody-Drug Conjugate Candidate into Clinical-stage 2021-02-01 08:09
Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been Granted Fast Track Designation by the U.S. FDA 2021-01-29 22:53
RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib 2021-01-29 20:26
2021 Japan Prize Laureates Announced 2021-01-29 14:00
Ascentage Pharma Announces the Fifth Orphan Drug Designation Granted to Bcl-2 Inhibitor APG-2575 by the US FDA, and the Tenth Obtained by the Company 2021-01-29 08:29
12-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at LINC 2021-01-29 01:46
RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals 2021-01-28 22:03
Covid-T™ Clinical Development Program Initiated Regulatory Advisory Group Engaged 2021-01-28 21:46
Zeus Launches Reinforced Polyimide Tubing 2021-01-28 21:00
Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil 2021-01-28 19:57
CROMSOURCE Consolidates Strategic Site Support Service 2021-01-28 19:00
Sai Life Sciences announces plans to double headcount and expand capabilities in Manchester, UK 2021-01-28 15:30
Harbour BioMed's Batoclimab (HBM9161) Receives China CDE Breakthrough Therapy Designation for Treatment of Adult Patients with Myasthenia Gravis 2021-01-28 12:54
Ortho Clinical Diagnostics Announces Pricing of Initial Public Offering 2021-01-28 11:38
CStone Pharmaceuticals Reports Efficacy and Safety Data from the ARROW Trial of Pralsetinib in Chinese Patients with Advanced RET Fusion-positive Non-Small Cell Lung Cancer after Platinum-based Chemotherapy at IASLC WCLC 2020 2021-01-28 10:15
Mallinckrodt Receives Approval in Japan of the CELLEX® Extracorporeal Photopheresis System for Treatment of Chronic Graft Versus Host Disease 2021-01-28 09:00
1 311 312 313 314 315 531